For its fourth fiscal quarter (ending June 30), Cimpress PLC (NASDAQ: CMPR) has reported E.P.S. of $4.55 compared to $1.09 a year ago. E.P.S. were $6.64 for the latest four quarters through June 30 versus […]
For its fourth fiscal quarter (ending June 30), Automatic Data Processing Inc (NASDAQ: ADP) has reported E.P.S. of $2.03 compared to $1.88 a year ago. E.P.S. were $9.14 for the latest four quarters through June […]
Universal Stainless & Alloy Prod (NASDAQ: USAP) has reported earnings for its second fiscal quarter (ending June 30) of $0.96 versus $0.10 for the same period a year ago. For the latest four quarters through […]
Tetra Tech Inc (NASDAQ: TTEK) has reported earnings for its third fiscal quarter (ending June 30) of $1.60 versus $1.13 for the same period a year ago. For the latest four quarters through June 30, […]
Important positive changes in Sarepta Therapeutics Inc (NASDAQ: SRPT) fundamentals have recently occurred: the consensus estimate for December, 2024 increased significantly, significant quarterly sales acceleration occurred, and the consensus estimate for December, 2025 increased significantly. […]
For its second fiscal quarter (ending June 30), Radware Ltd (NASDAQ: RDWR) has reported E.P.S. of $0.04 compared to $-0.13 a year ago. E.P.S. were $-0.29 for the latest four quarters through June 30 versus […]
Powell Industries Inc (NASDAQ: POWL) stock enjoyed a major increase of 37.8% on 7/31/24. The shares closed at $183.63. Moreover, this advance was accompanied by exceptionally high trading volume at 441% of normal. The stock […]
Columbus McKinnon Corp (NASDAQ: CMCO) has reported E.P.S. of $0.30 for its first fiscal quarter (ending June 30) versus $0.32 for the same period a year ago. For the latest four quarters through June 30, […]
Artio Global Investors Inc (NASDAQ: AVGO) stock closed at $160.68 on 7/31/24 after a major increase of 12.0%. This advance was accompanied by normal trading volume. The stock has declined -1.9% during the last week […]
For its second fiscal quarter (ending June 30), Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has reported E.P.S. of $-0.08 compared to $0.03 a year ago. E.P.S. were $-0.19 for the latest four quarters through June 30 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research